SynDRA canonical compound SYN0002113 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | FDPS |
| Mechanism of action | Bone resorption inhibitor |
| Indication | breast cancer | hypercalcemia | multiple myeloma | Paget's disease |
| Disease area | endocrinology | hematologic malignancy | oncology |